Pilot Study of the Osteo-Fluidic-Sensitive (OFS) in Tension-type Headache.
NCT ID: NCT05229224
Last Updated: 2026-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2022-11-29
2026-08-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Compare the efficacy of the Osteo-Fluidic-Sensitive method versus a placebo method on patients with tension type headache for the reduction of the number of days of headaches per month after 3 months of treatment at Centre Hospitalier Universitaire de Poitiers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Chronic Cluster Headache with TENS and ONS
NCT05023460
Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE
NCT01775735
Short-term Effectiveness of Transcutaneous Nerve Stimulation in Reducing Migraine Related Pain
NCT02438553
Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks
NCT00329732
Paracetamol With Caffeine to Treat Episodic Tension Type Headache
NCT01755702
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Osteo-Fluidic-Sensitive method
Osteo fluidic Sensitive méthod
Manual therapy, without manipulative treatment, based on rebalancing of the body with manual pressures on specific body areas.
Placebo method
Placebo method
Soft Manual pressures at specific points that are defined as non-effective and non-deleterious for patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Osteo fluidic Sensitive méthod
Manual therapy, without manipulative treatment, based on rebalancing of the body with manual pressures on specific body areas.
Placebo method
Soft Manual pressures at specific points that are defined as non-effective and non-deleterious for patients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Person having highly frequent episodic tension type headache (between 2 and 14 days of headaches per month) associated or not to headache with characteristic of a migraine per International Classification of Headache Disorders 3rd edition criteria
* Person who completed his headache agenda the month before the study.
* Patient who understands and accepts the effects of the study
* Signed consent
* Person with health insurance coverage
Exclusion Criteria
* Person on treatment of venlafaxine, gabapentine, duloxetine, clomipramine et toxine botulique.
* Concomitant participation to another clinical research
* Pregnant or lactating women, women of child-bearing age who do not have effective contraception.
* People with reinforced protection (juvenile), people deprived of liberty per justice or administrative decision, people living in a sanitary and social establishment, adults under legal protection and people in critical medical conditions
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Poitiers University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Helene KERSUZAN
Role: PRINCIPAL_INVESTIGATOR
CHU de Poitiers FRANCE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Poitiers
Poitiers, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CephalOFS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.